Embolization of hypervascular bone metastases reduces intraoperative blood loss: A case-control study Journal Article


Authors: Pazionis, T. J.; Papanastassiou, I. D.; Maybody, M.; Healey, J. H.
Article Title: Embolization of hypervascular bone metastases reduces intraoperative blood loss: A case-control study
Abstract: Small case series suggest that preoperative transcatheter arterial embolization minimizes bleeding and facilitates surgery for hypervascular metastatic bone tumors. However, control groups would make our confidence in clinical recommendations stronger, but small patient numbers make prospective trials difficult to conduct on this topic. In this case-control study, we asked whether (1) patients who undergo embolization have less estimated blood loss and/or shorter operative time than patients who do not have embolization; (2) larger tumor size, greater initial tumor vascularity, and longer interval from embolization to surgery are associated with greater estimated blood loss and packed red blood cell transfusion volume; and (3) embolization does not affect renal function in patients with normal preoperative renal function. We retrospectively reviewed records of patients with hypervascular bone metastases treated at our institution between 1998 and 2008. Twenty-seven patients with renal cell carcinoma and 12 with thyroid carcinoma who underwent embolization before 41 surgical procedures were matched to 41 patients who did not have embolization with respect to age, diagnosis, tumor size and potential vascularity, and procedure type; matching was performed without knowledge of outcomes. In univariate and multivariate analyses, age, tumor size, use of embolization, surgery type and risk, embolization-to-surgery interval, and degree of devascularization were evaluated for correlations with estimated blood loss, packed red blood cell transfusion volume, operative time, and postembolization renal function. Overall, patients who had embolization had less mean estimated blood loss (0.90 versus 1.77 L; p = 0.002), packed red blood cell transfusion volume (2.15 versus 3.56 U; p = 0.020), and operative time (3.13 versus 3.91 hours; p < 0.001). Larger tumor size correlated with greater estimated blood loss (r = 0.451; p = 0.003), packed red blood cell transfusion volume (r = 0.50; p = 0.002), and operative time (r = 0.595; p < 0.001). Neither the interval for embolization to surgery nor the degree of devascularization correlated with estimated blood loss or transfusion volume. In open rodding with intralesional curettage, transcatheter arterial embolization was associated with reduced estimated blood loss, transfusion volume, and operative time. Packed red blood cell transfusion volume was not reduced by embolization in intramedullary nailing procedures with the patient numbers available. Among patients with normal preoperative renal function who had embolization, creatinine levels remained normal. Mild transient, reversible renal function change occurred in one patient with preoperatively abnormal renal function. This study suggests that preoperative embolization probably reduces estimated blood loss, particularly for large tumors and during open femoral procedures.
Keywords: adult; treatment outcome; aged; aged, 80 and over; bone neoplasms; middle aged; bone tumor; retrospective studies; artificial embolism; pathophysiology; metastasis; tumor volume; risk factors; pathology; vascularization; retrospective study; risk factor; kidney carcinoma; kidney neoplasms; time; time factors; kidney; kidney tumor; carcinoma, renal cell; tumor burden; operation duration; multivariate analysis; thyroid neoplasms; erythrocyte transfusion; thyroid tumor; embolization, therapeutic; blood loss, surgical; orthopedic procedures; orthopedic surgery; operative time; very elderly; operative blood loss; humans; human; male; female; article
Journal Title: Clinical Orthopaedics and Related Research
Volume: 472
Issue: 10
ISSN: 0009-921X
Publisher: Springer  
Date Published: 2014-10-01
Start Page: 3179
End Page: 3187
Language: English
DOI: 10.1007/s11999-014-3734-3
PUBMED: 24964883
PROVIDER: scopus
PMCID: PMC4160496
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Majid Maybody
    98 Maybody
  2. John H Healey
    550 Healey